Muhlenkamp & CO Inc Gilead Sciences, Inc. Call Options Transaction History
Muhlenkamp & CO Inc
- $306 Million
- Q2 2024
Call Options
3 transactions
Others Institutions Holding GILD
# of Institutions
1,886Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$9.44 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$8.84 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$6.51 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.72 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$4.44 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $96.5B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...